Short Interest in Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Rises By 27.3%

Key Points

• Curaleaf Holdings, Inc. experienced a 27.3% increase in short interest from August 15th to August 31st, totaling 5,253,800 shares, which represents approximately 0.8% of its shares.
• The company's stock price rose by 1.4% to $2.58 during midday trading, with a market cap of $1.73 billion and a fifty-day moving average price of $2.16.
• Analysts have upgraded Curaleaf's rating from "hold" to "moderate buy," with an average rating of "Strong Buy" across analyst evaluations.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 5,253,800 shares, an increase of 27.3% from the August 15th total of 4,126,300 shares. Currently, 0.8% of the shares of the stock are sold short. Based on an average trading volume of 2,913,600 shares, the days-to-cover ratio is currently 1.8 days. Based on an average trading volume of 2,913,600 shares, the days-to-cover ratio is currently 1.8 days. Currently, 0.8% of the shares of the stock are sold short.

Curaleaf Trading Down 0.2%

Shares of CURLF stock traded down $0.01 on Friday, reaching $2.60. 1,187,235 shares of the company's stock were exchanged, compared to its average volume of 988,571. Curaleaf has a 52 week low of $0.68 and a 52 week high of $3.65. The company has a current ratio of 1.47, a quick ratio of 0.70 and a debt-to-equity ratio of 1.00. The stock has a market capitalization of $1.74 billion, a PE ratio of -8.13 and a beta of 0.78. The company's fifty day simple moving average is $2.25 and its 200 day simple moving average is $1.36.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative return on equity of 14.61% and a negative net margin of 18.08%. As a group, analysts forecast that Curaleaf will post -0.25 EPS for the current year.

Analyst Ratings Changes

Separately, Cormark raised Curaleaf from a "hold" rating to a "moderate buy" rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the company currently has an average rating of "Strong Buy".

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.